Latest Episodes
Exploring the role of targeted radiopharmaceutical treatment in NETs
How are advances in radioligand therapy shaping the treatment of neuroendocrine tumours, and what does recent trial evidence tell us? What are the key...
Short-stature conditions, including SPIGFD
Hear from Dr Andrew Dauber and Dr Marta Ramón Krauel in this podcast as they explore short stature conditions, including SPIGFD (severe primary IGF-1...
Neuroendocrine tumours (NETs) – Shared decision-making. Part 2: Individualising treatment decisions
In this second episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins...
Neuroendocrine tumours (NETs) – Shared decision-making. Part 1: Patient journey
In this first episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins...
Regional differences in NET: Treatment and future developments
In the second episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss how to optimize treatment for people living...
Regional differences in NET: Epidemiology, diagnosis, and referral strategies
In this first episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss regional differences in NET epidemiology, and patient...